OPTIC: Views on OPTimising Immune Checkpoint inhibition in cancer

Share this page:


The researchers for the OPTIC trial have conducted online discussion groups with kidney cancer patients and carers to talk about their views on the way that immunotherapy medicines are given for cancer.  These views could help shape future cancer research trials. Thank you to those of you who took part in these discussion groups.

You can find all of the information about the study in the participant information sheet by clicking here or you can read the participant information sheet on the OPTIC website by clicking here or on the image opposite. 

The findings from this study have been written up in a paper which is undergoing final review before publication. When the results are available we will share them on this page.

Share this page: